Anti-Carcinoembryonic antigen/CEA antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | Carcinoembryonic antigen |
| Immunogen: | Recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:400); Immunocytochemistry/Immunofluorescence (1:100-1:200); Immunohistochemistry (1:100-1:200) |
| Reactivity: | Human |
| Clonality (clone number): | Monoclonal, JM93-28 |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1% BSA, 0.05% NaN3 and 40% Glycerol. |
| Concentration: | 1mg/ml |
| Purity: | Protein A/G affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Carcinoembryonic antigen antibody |
| Carcinoembryonic antigen-related cell adhesion molecule 5 antibody | |
| CD66e antibody | |
| CEA antibody | |
| Ceacam5 antibody | |
| CEAM5_HUMAN antibody | |
| DKFZp781M2392 antibody | |
| Meconium antigen 100 antibody | |
| OTTHUMP00000199032 antibody | |
| OTTHUMP00000199033 antibody | |
| OTTHUMP00000199034 antibody |
Show More
Target information
Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression (PubMed:2803308, PubMed:10910050, PubMed:10864933). Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed:2803308). Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells (PubMed:10910050).
Provider
Erpantech Laboratory
